Washington University, The
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 510 S. Kingshighway Blvd, Saint Louis, Missouri (MO) 63110, United States (USA)
- Operations here
- positron emission tomography drug production
- FDA identifiers
- FEI 3009930596 · DUNS 618078752
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-03-21
- VAIDrug Quality Assurance2016-04-01
- VAIDrug Quality Assurance2013-09-24
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- Fludeoxyglucose F 18Washington University School of Medicine
- Nh3n13Washington University School of Medicine
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.